nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—PLA2G4A—ADP signalling through P2Y purinoceptor 1—GNA11—ocular cancer	0.0533	0.0533	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—ADP signalling through P2Y purinoceptor 1—GNAQ—ocular cancer	0.0496	0.0496	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signal amplification—GNA11—ocular cancer	0.0449	0.0449	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signal amplification—GNAQ—ocular cancer	0.0417	0.0417	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CRTC1—ocular cancer	0.0371	0.0371	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—E2F5—ocular cancer	0.0274	0.0274	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—E2F4—ocular cancer	0.0269	0.0269	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RBL1—ocular cancer	0.0264	0.0264	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—GNA11—ocular cancer	0.0255	0.0255	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—GNAQ—ocular cancer	0.0237	0.0237	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RBBP4—ocular cancer	0.0229	0.0229	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—TFDP1—ocular cancer	0.0213	0.0213	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.0191	0.0191	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.0188	0.0188	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—E2F4—ocular cancer	0.0184	0.0184	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—RBL1—ocular cancer	0.0181	0.0181	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of Androgen receptor activity—HDAC1—ocular cancer	0.0173	0.0173	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—RBL2—ocular cancer	0.0166	0.0166	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC1—ocular cancer	0.0123	0.0123	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—HDAC1—ocular cancer	0.0122	0.0122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—p38 MAPK Signaling Pathway—MYC—ocular cancer	0.0121	0.0121	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—ocular cancer	0.0111	0.0111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—ocular cancer	0.00974	0.00974	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—ocular cancer	0.00954	0.00954	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00933	0.00933	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—ocular cancer	0.00921	0.00921	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—ocular cancer	0.00876	0.00876	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.00867	0.00867	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of Androgen receptor activity—MDM2—ocular cancer	0.00862	0.00862	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGF Pathway—HRAS—ocular cancer	0.00854	0.00854	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—ocular cancer	0.00828	0.00828	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00788	0.00788	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.00731	0.00731	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00723	0.00723	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—E2F1—ocular cancer	0.00696	0.00696	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of Androgen receptor activity—EP300—ocular cancer	0.00691	0.00691	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—E2F5—ocular cancer	0.00686	0.00686	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—E2F4—ocular cancer	0.00673	0.00673	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Circadian Clock—EP300—ocular cancer	0.00671	0.00671	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—RBL1—ocular cancer	0.0066	0.0066	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CDKN1B—ocular cancer	0.0063	0.0063	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00623	0.00623	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PSPH—ocular cancer	0.0062	0.0062	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—ocular cancer	0.00608	0.00608	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CCND1—ocular cancer	0.00601	0.00601	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—ocular cancer	0.00597	0.00597	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00589	0.00589	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—HRAS—ocular cancer	0.00582	0.00582	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SF3B1—ocular cancer	0.00564	0.00564	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—EP300—ocular cancer	0.00553	0.00553	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—TFDP1—ocular cancer	0.00532	0.00532	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—ocular cancer	0.00527	0.00527	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.00517	0.00517	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—AKT1—ocular cancer	0.00514	0.00514	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—ocular cancer	0.00512	0.00512	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—AKT1—ocular cancer	0.00495	0.00495	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—RB1—ocular cancer	0.00493	0.00493	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.00492	0.00492	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—TGFB1—ocular cancer	0.00492	0.00492	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—ocular cancer	0.00487	0.00487	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.00485	0.00485	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—MYC—ocular cancer	0.00482	0.00482	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TGFB1—ocular cancer	0.00481	0.00481	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—GNA11—ocular cancer	0.00481	0.00481	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—GNAQ—ocular cancer	0.00447	0.00447	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00437	0.00437	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.00429	0.00429	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—MYC—ocular cancer	0.00428	0.00428	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—MAML2—ocular cancer	0.00422	0.00422	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—HDAC1—ocular cancer	0.00403	0.00403	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00399	0.00399	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EIF1AX—ocular cancer	0.00397	0.00397	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TP53—ocular cancer	0.00396	0.00396	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00381	0.00381	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00368	0.00368	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—CDKN1A—ocular cancer	0.00354	0.00354	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.0035	0.0035	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.00349	0.00349	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SAG—ocular cancer	0.00343	0.00343	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—HRAS—ocular cancer	0.00337	0.00337	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—E2F5—ocular cancer	0.00331	0.00331	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—E2F4—ocular cancer	0.00324	0.00324	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RBL1—ocular cancer	0.00318	0.00318	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RPL39—ocular cancer	0.00318	0.00318	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—HDAC1—ocular cancer	0.00309	0.00309	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00305	0.00305	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00304	0.00304	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—E2F5—ocular cancer	0.00304	0.00304	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—E2F4—ocular cancer	0.00298	0.00298	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.00297	0.00297	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.00295	0.00295	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TGFB1—ocular cancer	0.00293	0.00293	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RBL1—ocular cancer	0.00292	0.00292	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00291	0.00291	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CDK2—ocular cancer	0.00286	0.00286	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00277	0.00277	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GNA11—ocular cancer	0.00276	0.00276	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—RBBP4—ocular cancer	0.00275	0.00275	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00271	0.00271	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GNAQ—ocular cancer	0.00257	0.00257	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—TFDP1—ocular cancer	0.00256	0.00256	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—E2F3—ocular cancer	0.00253	0.00253	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00251	0.00251	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TFDP1—ocular cancer	0.00235	0.00235	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00212	0.00212	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MAML2—ocular cancer	0.00203	0.00203	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GNA11—ocular cancer	0.00195	0.00195	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.00188	0.00188	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MAML2—ocular cancer	0.00187	0.00187	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GNAQ—ocular cancer	0.00181	0.00181	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNA11—ocular cancer	0.00163	0.00163	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—EP300—ocular cancer	0.00161	0.00161	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNAQ—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HDAC1—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TGFB1—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HDAC1—ocular cancer	0.00137	0.00137	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—CDKN2B—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN2B—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—ocular cancer	0.00115	0.00115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—E2F1—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—HRAS—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—MYC—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—ocular cancer	0.000971	0.000971	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MDM2—ocular cancer	0.000679	0.000679	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—EP300—ocular cancer	0.000651	0.000651	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HRAS—ocular cancer	0.000631	0.000631	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1B—ocular cancer	0.00062	0.00062	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCND1—ocular cancer	0.000592	0.000592	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDKN1A—ocular cancer	0.000572	0.000572	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—ocular cancer	0.000557	0.000557	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—EP300—ocular cancer	0.000545	0.000545	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—MYC—ocular cancer	0.000517	0.000517	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MYC—ocular cancer	0.000475	0.000475	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFB1—ocular cancer	0.000473	0.000473	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—ocular cancer	0.000394	0.000394	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—ocular cancer	0.00039	0.00039	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HRAS—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—ocular cancer	0.000358	0.000358	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—ocular cancer	0.000329	0.000329	CbGpPWpGaD
